EUVIMEDEUVIMED entdecken
Open Access

Vascular Endothelial Growth Factor-D Improves Lung Vascular Integrity During Acute Lung Injury

Yongdae Yoon iD, Lokesh Sharma iD, Wenwen Tang, Shannon Kirk, Micha Sam Brickman Raredon iD, Farida Ahangari iD, Johad Khoury iD, Hong Qian, Yunbo Ke iD, Mohan E Tulapurkar, Ruya Liu iD, Yi Luan und 8 weitere

Circulation Research · 24.04.2026 · 138 (9)

DOI: 10.1161/circresaha.124.326094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, erschienen am 24.04.2026. Verfasst von Yongdae Yoon und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology (Y. Yoon, S.K., Y.K., K.G.B., Y. Yuan), University of Maryland School of Medicine, Baltimore. Hauptthemen laut MEDLINE: Acute Lung Injury, Lung, Vascular Endothelial Growth Factor D, Capillary Permeability. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Disorders in pulmonary vascular integrity are a prominent feature in many lung diseases. Paracrine signaling is highly enriched in the lung and plays a crucial role in regulating vascular homeostasis. However, the specific local cell-cell crosstalk signals that maintain pulmonary microvascular stability in adult animals and humans remain largely unexplored. METHODS: In this study, we used single-cell RNA-sequencing–based computational pipelines to systematically profile ligand-receptor interactions within the lung microvascular niche and identified VEGF-D (vascular endothelial growth factor-D) as a key local factor with previously unrecognized barrier-protective properties in models of acute lung injury. RESULTS: Our single-cell RNA-sequencing data revealed that, under physiological conditions, soluble ligand-receptor interactions between mesenchymal cells, in particular alveolar fibroblasts, and microvascular endothelial cells are predominantly associated with pathways involved in maintaining vascular integrity as compared with all other cells. On treatment with top identified ligands, we found that VEGF-D significantly enhanced endothelial barrier function and conferred protection against inflammatory challenges induced by TNF-α (tumor necrosis factor-α), IL (interleukin)-1β, and thrombin. This barrier-protective effect of VEGF-D was significantly attenuated by inhibition of VEGFR2 (vascular endothelial growth factor receptor 2), either through small interfering RNA (siRNA) knockdown or pharmacological blockade using specific VEGFR2 inhibitors. Intravenous administration of recombinant VEGF-D in lipopolysaccharide-induced acute lung injury models significantly reduced vascular permeability (7339±2510 arbitrary unit [a.u.] [lipopolysaccharides] versus 5350±1821 a.u. [lipopolysaccharides+VEGF-D]; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryLungVascular Endothelial Growth Factor DCapillary PermeabilityAnimalsMice, Inbred C57BLMiceVascular Endothelial Growth Factor Receptor-2Endothelial CellsMaleHumansMice, KnockoutParacrine CommunicationDisease Models, Animal

Stichwörter der Autor:innen

endothelial cellshomeostasisinflammationintercellular junctionslung injury

Substanzen

Vascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor DKdr protein, mouse

Autor:innen und Institutionen

  • Department of Anesthesiology (Y. Yoon, S.K., Y.K., K.G.B., Y. Yuan), University of Maryland School of Medicine, Baltimore.
  • Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine (L.S., F.A., J.K., N.K., Y. Yuan), Yale School of Medicine, New Haven, CT.
  • Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh Medical Center, PA (L.S.).
  • Department of Pharmacology (W.T., Y.L., Q.Y., D.W.), Yale School of Medicine, New Haven, CT.
  • Vascular Biology & Therapeutics Program (W.T., M.S.B.R., H.Q., Y.L., Q.Y., M.S., D.W., L.E.N., Y. Yuan), Yale School of Medicine, New Haven, CT.
  • Department of Anesthesiology (M.S.B.R., H.Q., L.E.N., Y. Yuan), Yale School of Medicine, New Haven, CT.

ORCID-Profile: Yongdae Yoon, Lokesh Sharma, Micha Sam Brickman Raredon, Farida Ahangari, Johad Khoury, Yunbo Ke, Ruya Liu, Lujia Chen, Konstantin G Birukov, Michael Simons, Laura E Niklason, Naftali Kaminski, Yifan Yuan

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Yoon, Y., Sharma, L., Tang, W., Kirk, S., Raredon, M. S. B., Ahangari, F., Khoury, J., Qian, H., Ke, Y., Tulapurkar, M. E., Liu, R., Luan, Y., Yuan, Q., Chen, L., Birukov, K. G., Simons, M., Wu, D., Niklason, L. E., Kaminski, N., & Yuan, Y. (2026). Vascular Endothelial Growth Factor-D Improves Lung Vascular Integrity During Acute Lung Injury. Circulation Research, 138(9). https://doi.org/10.1161/circresaha.124.326094

Vancouver

Yoon Y, Sharma L, Tang W, Kirk S, Raredon MSB, Ahangari F, et al. Vascular Endothelial Growth Factor-D Improves Lung Vascular Integrity During Acute Lung Injury. Circulation Research. 2026;138(9). doi:10.1161/circresaha.124.326094

BibTeX
@article{Yoon2026,
  author = {Yoon, Yongdae and Sharma, Lokesh and Tang, Wenwen and Kirk, Shannon and Raredon, Micha Sam Brickman and Ahangari, Farida and Khoury, Johad and Qian, Hong and Ke, Yunbo and Tulapurkar, Mohan E and Liu, Ruya and Luan, Yi and Yuan, Qianying and Chen, Lujia and Birukov, Konstantin G and Simons, Michael and Wu, Dianqing and Niklason, Laura E and Kaminski, Naftali and Yuan, Yifan},
  title = {Vascular Endothelial Growth Factor-D Improves Lung Vascular Integrity During Acute Lung Injury},
  journal = {Circulation Research},
  year = {2026},
  volume = {138},
  number = {9},
  doi = {10.1161/circresaha.124.326094}
}
Kostenlos starten →